Marathi | HIndi

Epaper
Follow us:
Home > Topic > Shekhar mande
Shekhar mande

Shekhar mande

Shekhar C. Mande is a Structural and Computational Biologist. He did his M.Sc. in Physics from University of Nagpur. He holds Doctor of philosophy in Molecular Biophysics, from the Indian Institute of Science. Following his PhD, he joined Prof. Wim G. J.

Read more
Drug discovery hackathon can yield COVID-19 solution
National

Drug discovery hackathon can yield COVID-19 solution

The drug discovery hackathon, a joint initiative of All India Council for Technical Education (AICTE) and Council of Scientific and Industrial Research (CSIR), can yield to some novel solution for COVID-19, said Shekhar Mande, Director-General, CSIR.

Drug Umifenovir secures nod for clinical trial for Covid-19
Health

Drug Umifenovir secures nod for clinical trial for Covid-19

Amid the race to find a cure for the deadly coronavirus infection, Council of Scientific and Industrial Research (CSIR)-constituent ...

Maharashtra govt approves formation of AYUSH task force
Maharashtra

Maharashtra govt approves formation of AYUSH task force

The Maharashtra government has approved the formation of a task force which will give recommendations to it to incorporate AYUSH treatment modalities specifically for increasing immunity against COVID-19, said the state medical education and drug department.

Trials for four Ayush formulations against COVID-19 to start within a week
National

Trials for four Ayush formulations against COVID-19 to start within a week

The AYUSH Ministry and the Council of Scientific and Industrial Research (CSIR) are working together on validating four Ayush formulations against COVID-19 and the trials will start within one week.

CSIR to begin two clinical drug trials to combat COVID-19
National

CSIR to begin two clinical drug trials to combat COVID-19

The Council for Scientific and Industrial Research (CSIR) has received approval from Drug Controller General of India (DGCI) for its two clinical trial drugs - 'favipiravir' and 'phytopharmaceutical' - to combat coronavirus.The CSIR is exploring a native herb as a biological medicine or phytopharmaceutical, which is already being tested as medicine for dengue for its efficacy to combat COVID-19.The DCGI has given us approval for clinical trials of two drugs so we will soon begin with it," he said.

Time ripe to try Ayurvedic formulations: CSIR DG on clinical trials of AYUSH
National

Time ripe to try Ayurvedic formulations: CSIR DG on clinical trials of AYUSH

With the clinical trial of Ayush medicines beginning on Thursday, the Council of Scientific and Industrial Research (CSIR) Director-General Shekhar Mande said that the time is absolutely ripe currently to try out some of the traditional Ayurvedic formulations amid the corona battle."Clinical trials of Ayush medicines like Ashwagandha, Yashtimadhu, Guduchi Pippali, Ayush-64 on health workers and those working in high-risk areas has begun from today," he said.

COVID-19: AIIMS Bhopal conducting multicentric study on Mycobacterium w
National

COVID-19: AIIMS Bhopal conducting multicentric study on Mycobacterium w

"AIIMS Bhopal is conducting a study on Mycobacterium w (Mw) efficacy and safety in COVID-19 situation after due approval from AIIMS Bhopal ethical committee," the hospital administration said in a press note on Thursday.The hospital said that a total of 42 COVID-19 patients are presently admitted in AIIMS, Bhopal.

Mycobacterium w has trial started: CSIR Director
National

Mycobacterium w has trial started: CSIR Director

The Council of Scientific and Industrial Research (CSIR) Director Shekhar Mande on Monday said that trial of Mycobacterium w (Mw) has started.

Most Popular Stories

Corona
Patients5214677
Died84372
Corona
Patients30,673,106
Died955,492
Corona
Coronavirus Live updates! Around the world